Abbott Heart Rhythm Management Devices

Dr. Avi Fischer, M.D., Divisional Vice President, MedicalAffairs, and Chief Medical Officer for Cardiac RhythmManagement (CRM) at Abbott discusses the recent FDA approval of the next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The new devices offer built-in smartphone connectivity via Bluetooth for increased patient-physician engagement and streamlined communications. The Gallant high voltage platforms connect to Abbott’s secure myMerlinPulse™ mobile app to allow for continuous remote monitoring and seamlessly integrates into people’s day-to-day lives.
#ICD #CRTD #Abbott
Visit our website
www.healtprofessionalradio.com.au
Follow us on our social media channels
Facebook: / hprfm
Twitter: / healthproradio
Google+: plus.google.com/+HealthProfes...
Pinterest: / healthprora. .
Linkedin: / heal. .
Instagram: / healthprofe. .
Subscribe to our podcast channels
Soundcloud: / healthprofessi. .
Itunes: itunes.apple.com/nz/podcast/h...
Support us on Patreon
/ hpr